Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Jules Mitchell

18 indexed publications match this author name.

ORCID: 0000-0002-7567-8129
OpenAlex: https://openalex.org/A5078452831

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Safety 9 Depression 7 Clinical Trial 6 Brain Imaging 5 Healthy Volunteers 5 Chronic Pain 5 Mechanism of Action 4 Aging 4 Toxicity 3 Observational Study 3 Eating Disorders 2 Receptor Pharmacology 2

Journals

PsyArXiv 2 Human Brain Mapping 1 ClinicalTrials.gov 1 Psychoactives 1 Philosophical Psychology 1 Australian & New Zealand Journal of Psychiatry 1 Berkeley Scientific Journal 1 bioRxiv 1

Publication history

Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic Circuits.Human Brain Mapping · 2026-06-30 A Double Blind, Randomized Trial Investigating the Safety, Feasibility, and Mechanisms of Psychedelics in Healthy Older Adults With Low Well-being as Moderated by Biomarkers for Preclinical Alzheimer's DiseaseClinicalTrials.gov · 2026-06-07 Neural correlates of insight on psilocybin: a within-subjects, healthy volunteer studyUnknown journal · 2026-05-07 Psilocybin for Treatment of Prolonged Grief Disorder: An Open-Label Feasibility Study ProtocolPsychoactives · 2026-04-12 Observing the mind under psychedelics: conceptual metaphors used following four once-weekly macrodoses of psilocybinPhilosophical Psychology · 2026-04-09 Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia’s clinical landscapeAustralian & New Zealand Journal of Psychiatry · 2025-12-16 Comparative Efficacy of Psilocybin and MDMA in PTSD Treatment: A Systematic Review of Long-Term OutcomesBerkeley Scientific Journal · 2025-11-12 Long-term effects of psilocybin on dynamic and effectivity connectivity of fronto-striatal-thalamic circuitsbioRxiv · 2024-11-06 Psilocybin-assisted therapy and HIV-related shameScientific Reports · 2024-08-01 Who believes psychedelic-assisted therapies work? Risky cannabis use and other factors are associated with positive treatment-outcome expectanciesPsyArXiv · 2024-06-09 Do undergraduates’ views of psychedelics relate to the context for psychedelic use?PsyArXiv · 2024-04-23 Commentary: Evidence-Informed Recommendation to Achieve Approximate Parity in the Allowed Number of Doses for Common Psychedelics.Journal of psychoactive drugs · 2023-12-31 A Phase I trial to inform clinical protocols for the safe administration of psilocybin-assisted psychotherapymedRxiv · 2023-04-18 Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dying.PLoS ONE · 2022-08-23 Inconsistencies between national drug policy and professional beliefs about psychoactive drugs among psychiatrists in the United States.Unknown journal · 2022-08-10 Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine.Unknown journal · 2020-11-29 Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot studyEClinicalMedicine · 2020-09-23 T137. Psilocybin-Assisted Group Therapy for Demoralization in Long-Term AIDS SurvivorsBiological Psychiatry · 2019-04-30

Author directory